LON:OPTS - Optos Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeGBX 163 - GBX 355
VolumeN/A
Average Volume747,598 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Optos plc is a medical technology company, which is engaged in the design, development, manufacturing and marketing of ultra-wide field (UWF) retinal imaging devices. The Company provides devices to eye care professionals. Its products, Daytona and California, represents its UWF retinal imaging technology, and have been converted to desktop models. Its devices include image modalities, such as color, red-free and auto fluorescence (AF). In addition, the Daytona plus device comes with the OptosAdvance browser-based image review software, which allows for documentation, monitoring and referral processing to assist in patient management. California features fluorescein angiography (FA) and UWF imaging modality, indocyanine green angiography. The Company's devices produce UWF digital images (optomap) of approximately 82% or 200 degree of the retina. Its imaging devices for disease management and treatment support ophthalmologists and retinal specialists in the medical care market.

Receive OPTS News and Ratings via Email

Sign-up to receive the latest news and ratings for OPTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+44-1383-843300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Optos (LON:OPTS) Frequently Asked Questions

What is Optos' stock symbol?

Optos trades on the London Stock Exchange (LON) under the ticker symbol "OPTS."

Has Optos been receiving favorable news coverage?

News headlines about OPTS stock have trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Optos earned a media sentiment score of -1.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.

How do I buy shares of Optos?

Shares of OPTS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Optos' official website?

The official website for Optos is http://www.optos.com/.

How can I contact Optos?

Optos' mailing address is Queensferry House Carnegie Campus, Enterprise Way, DUNFERMLINE, KY11 8GR, United Kingdom. The company can be reached via phone at +44-1383-843300.


MarketBeat Community Rating for Optos (LON OPTS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  211 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  369
MarketBeat's community ratings are surveys of what our community members think about Optos and other stocks. Vote "Outperform" if you believe OPTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OPTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/22/2019 by MarketBeat.com Staff

Featured Article: Municipal Bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel